- Abstract
- Core Tip
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (93)
- Timeline of Article Publication Processes (14)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (253) -
Full Article (PDF) (76) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6268)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2019 (publication date) through Jul 3, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, Burgos CB, Sempere J. Diagnostic-therapeutic management of bile duct cancer. World J Clin Cases 2019; 7(14): 1732-1752 [PMID: 31417920 DOI: 10.12998/wjcc.v7.i14.1732] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i14/1732.htm |
| Number | Citing Articles |
| 1 |
Alireza Nemati, Mohamad Sadegh Aghajanzadeh, Mahdi Rooberahan. An Overview on Cancer Diagnosis based on Antibody-Based Immune Techniques. Modern Medical Laboratory Journal 2020; 3(2): 100 doi: 10.30699/mmlj17.3.1.100
|
| 2 |
Dina Ioffe, Pooja Phull, Efrat Dotan. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review. Cancer Management and Research 2021; : 8085 doi: 10.2147/CMAR.S276104
|
| 3 |
Cosmas Rinaldi Adithya Lesmana, Baiq Kirana D. Mandasari. Immunosuppression. 2020; doi: 10.5772/intechopen.94754
|
| 4 |
Nhu-An Pham, Nikolina Radulovich, Emin Ibrahimov, Sebastiao N. Martins-Filho, Quan Li, Melania Pintilie, Jessica Weiss, Vibha Raghavan, Michael Cabanero, Robert E. Denroche, Julie M. Wilson, Cristiane Metran-Nascente, Ayelet Borgida, Shawn Hutchinson, Anna Dodd, Michael Begora, Dianne Chadwick, Stefano Serra, Jennifer J. Knox, Steven Gallinger, David W. Hedley, Lakshmi Muthuswamy, Ming-Sound Tsao. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90049-1
|
| 5 |
Gülşah BAYRAM ILIKAN, İ̇lkay AKMANGİT. Percutaneous Transhepatic Cholangiography, Percutaneous Biliary Drainage and Metallic Endoprotesis Applications in Malign Biliary Obstructions. Journal of Contemporary Medicine 2020; 11(1): 97 doi: 10.16899/jcm.764141
|
| 6 |
Jieling Zheng, Shaobo Yao. [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer. European Journal of Nuclear Medicine and Molecular Imaging 2020; 47(9): 2078 doi: 10.1007/s00259-020-04847-2
|
| 7 |
Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J Borad, Ghassan K Abou-Alfa, Ping Jiang, Christine F Lihou, Huiling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements. Future Oncology 2020; 16(30): 2385 doi: 10.2217/fon-2020-0429
|
| 8 |
Josep Darbà, Alicia Marsà. Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018). Expert Review of Pharmacoeconomics & Outcomes Research 2021; 21(3): 425 doi: 10.1080/14737167.2021.1842201
|